Le Lézard
Classified in: Health, Science and technology
Subject: CSR

UF/Sid Martin Biotechnology Institute Company MLM Biologics Inc. Sends Wound Care and Microbial Supplies to Devastated Puerto Rico


GAINESVILLE, Fla., Oct. 9, 2017 /PRNewswire/ -- Sid Martin Biotechnology Institute, the leading biotechnology incubator at the University of Florida, reports that resident company MLM Biologics Inc., a medical device start-up company focused on advanced wound care and musculoskeletal innovation, has responded with humanitarian help for needy patients in Puerto Rico following the Hurricane Maria devastation to the island.

Chandra Nataraj, Ph.D., Chief Executive Officer, MLM Biologics, said, "When we saw the crisis unfolding in Puerto Rico after the hurricane's destruction, we wanted to help as an organization. Our mission is to help patients worldwide and it's an emergency situation there so we mobilized to get wound care supplies to them."

Coordinating their efforts with MMM Healthcare, the first Medicare Advantage health plan provider in Puerto Rico, MLM Biologics participated in the airlift of medical supplies for the Puerto Rican elderly and special needs population. ReliOx Corporation, another Sid Martin Biotechnology Institute resident company, also participated in the relief efforts. 

MLM Biologics' health care network solutions partner, Trinity-Pharmaco Solutions, helped facilitate the handover of the first shipment of wound care and anti-microbial supplies, valued at more than $75,000. The supplies arrived in Puerto Rico Oct. 1st

Merrie Shaw, Assistant Director of the Sid Martin Biotechnology Institute, said, "MLM Biologics' patient welfare efforts are another wonderful example of how our resident companies continue to feed, fuel and heal the world."

About MLM Biologics Inc.

MLM Biologics is a medical device startup company focused on the advanced wound care and musculoskeletal markets. A resident company of the Sid Martin Biotechnology Institute, the company is currently commercializing its advanced wound care product, the bio-ConneKt® Wound Matrix. This FDA-cleared all-biologic device is clinically- and cost-effective, and designed to serve the needs of patients and doctors worldwide. For more information visit MLM Biologics.

About Sid Martin Biotechnology Institute at the University of Florida
The Sid Martin Biotechnology Institute is the leading biotechnology incubator headquartered at the University of Florida in Alachua, Florida at Progress Park. The Institute has been honored with national and international awards for incubator excellence and achievements in technology commercialization, funding access, job creation and technology-based economic development. It is dedicated to mentoring and accelerating the growth of innovative early-stage bioscience and biotechnology companies, and supporting the economic growth of the North Central Florida region.  For more information, visit SidMartinBio.com.

Contacts:
Chandra Nataraj, Ph.D., CEO, MLM Biologics Inc., 1-844-465-6246, [email protected], www.mlmbiologics.com

Merrie Shaw, Assistant Director, Sid Martin Biotechnology Institute,  386-462-0880, [email protected]www.sidmartinbio.com                                                                             

Related Images

image1.png
Sid Martin Biotechnology Institute - University of Florida

image2.jpg
MLM Biologics Inc.

SOURCE Sid Martin Biotechnology Institute


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: